These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16280334)

  • 21. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic risk during antipsychotic treatment.
    Newcomer JW
    Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
    Chue P
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.
    Papadimitriou GN; Theleritis CG; Dikeos DG; Psarros CJ; Soldatos CR
    Int Clin Psychopharmacol; 2006 May; 21(3):181-4. PubMed ID: 16528141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
    Vohora D
    Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
    Popp J; Leucht S; Heres S; Steimer W
    Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Weight gain from atypical neuroleptics--an underreported adverse effect?].
    Wetterling T
    Fortschr Neurol Psychiatr; 2000 Dec; 68(12):546-56. PubMed ID: 11200858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical antipsychotics and weight gain.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):46-58. PubMed ID: 19667655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment.
    Ryu S; Cho EY; Park T; Oh S; Jang WS; Kim SK; Lee D; Hong KS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):673-7. PubMed ID: 17275977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy.
    Huang TL; Lu CY
    Chang Gung Med J; 2007; 30(1):26-32. PubMed ID: 17477026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine and weight gain.
    Umbricht DS; Pollack S; Kane JM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():157-60. PubMed ID: 7961563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.
    Meltzer HY
    J Clin Psychiatry; 2001; 62 Suppl 27():35-9; discussion 40-1. PubMed ID: 11806488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight gain and antipsychotic medication.
    Blackburn GL
    J Clin Psychiatry; 2000; 61 Suppl 8():36-41; discussion 42. PubMed ID: 10811242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight effects associated with antipsychotics: a comprehensive database analysis.
    Parsons B; Allison DB; Loebel A; Williams K; Giller E; Romano S; Siu C
    Schizophr Res; 2009 May; 110(1-3):103-10. PubMed ID: 19321312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight gain on antipsychotic medication is associated with sustained use among veterans with schizophrenia.
    Monnelly EP; Fonda J; Gagnon DR; Chittamooru S; Lawler EV
    J Clin Psychopharmacol; 2015 Feb; 35(1):57-62. PubMed ID: 25514067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight gain associated with use of psychotropic medications.
    Sachs GS; Guille C
    J Clin Psychiatry; 1999; 60 Suppl 21():16-9. PubMed ID: 10548137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weight change from 3-year observational data: findings from the worldwide schizophrenia outpatient health outcomes database.
    Bushe CJ; Slooff CJ; Haddad PM; Karagianis JL
    J Clin Psychiatry; 2012 Jun; 73(6):e749-55. PubMed ID: 22795214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.
    Hasnain M; Vieweg WV; Hollett B
    Postgrad Med; 2012 Jul; 124(4):154-67. PubMed ID: 22913904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.